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The tempo and severity of graft-versus-host  (GVH)  1 disease  in Syrian hamsters is 
strongly influenced by the dose and route of parental strain lymphoid cell inoculation 
(1, 2).  If upwards of 50 million MHA strain cells are injected intracutaneously into 
adult (CB  ×  MHA)F1 hybrid hosts, death intervenes within 2-3 wk. Alternatively, 
200  million MHA  lymphoid cells  delivered intravenously induce a  more subacute 
process,  one that extends through the ensuing 4-6 wk and from which many animals 
"recover," giving the outward appearance of well-being. However,  their continued 
susceptibility over the following  months to sudden death and a  variety of wasting 
syndromes suggests  that an ongoing, though subrosa,  systemic GVH reactivity per- 
sists. Field and Gibbs (3), have reported that rats who have recovered from acute GVH 
disease were  "refractory" to a subsequent challenge with lymphoid cells isologous  to 
the original donors, i.e.,  a second inoculation of donor-type cells failed to evoke the 
same acute GVH syndrome as did the first. The findings to be reported will document 
that F, hybrid hamsters that have survived the early phases of GVH disease are simi- 
larly refractory to a subsequent challenge with lymphoid cells of the original donor 
genotype. Evidence linking the  pathogenesis of  this phenomenon to  alterations in 
immunologic competency of GVH-ravaged hosts as well as changes in their lymphatic 
tissue mass will be presented. 
Materials and Methods 
Experimental A nimals.--Three  isogenic strains of domestically maintained Syrian hamsters 
(MHA, CB, and PD4) and their appropriate F1 hybrid progeny were employed in these experi- 
ments. Since the median survival times of exchanged skin homografts among these strains is 
characteristically less than 12 days (4; S. Zakarian, personal communication), it is very likely 
that each possesses a unique allele at the major histocompatibility locus operant in this species. 
(CB)<  MHA)F1 hybrids between 3 and 6 months of age regularly served as hosts for  the 
study of graft-versus-host disease incited by lymphoid cells of MHA strain origin. 
Lymph Node Cell Suspenslons.--Suspensions  were prepared  as previously described (5). 
In the induction of graft-versus-host disease, 200 X  106 MHA-anti-CB  cells were delivered 
* Markle Scholar in Academic Medicine. 
1  Abbre~ations used in tMs paper: GVH, graft-versus-host; ILTR, immune lymphocyte 
transfer reaction; MST, median survival time; TEN, toxic epidermal necrolysis; TT, tetanus 
toxoid. 
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either as a single bolus of 0.5 cc through a 30 gauge needle into the long saphenous vein, or into 
multiple cutaneous sites where 0.I cc portions of 10 million cells each served to initiate local 
GVH reactions, immune lymphocyte transfer reactions. 
Immune Lymplwcyte Transfer Reaction.  Reaction sites were evaluated and scored at 24 
and 48 hr as previously described (6). An animal was considered as reactive in this regard if a 
mean value greater than one plus was obtained by averaging its reaction scores. 
Skin  Grafting.--Skin  grafting  was  executed  and  scored  according  to  the  technique  of 
Billingham and Silvers (7). When necessary, specific sensitivity was boosted by exposure to a 
second skin graft or by intracutaneous injection of lymphoid cell suspensions  from the same 
donor strain.  Lymphoid cells used  to initiate  graft-versus-host disease were obtained  from 
donors sacrificed  1 wk after boosting. 
Tetanus Toxoid [mmunization.--Immunization  was  attempted  by  inoculating recipients 
intracutaneously with five 0.1  ml injections of alum-precipitated tetanus  toxoid  2 on days  1 
and 29, followed by an intraperitoneal injection of 0.5 cc of aqueous tetanus toxoid  3 on day 36. 
Sera from immunized animals were tested for circulating antibodies by gel diffusion  (8)  on 
days  26,  35,  47,  and  55. 
Whole Body X-lrradiation.--Whole  body X-irradiation designed to deliver a total of 900 R 
was carried out with a 200 kv X-ray source as described elsewhere (9). 
Bone Marrow Cell Suspensions.--Suspensions were obtained from appropriate  donors  by 
flushing  femurs, tibiae, and  humeri with Hanks'  balanced salt solution. To reconstitute  ir- 
radiated animals, one donor equivalent of bone marrow cells was injected intravenously 24 hr 
after X-ray exposure. 
EXPERIMENTS  AND  RESULTS 
Previous  studies  have  shown  that  the  lymphoid  apparatus  of  F1  hybrid 
hosts  is  the  primary  inmmnologic  focus  of  attacking  donor  cells  in  hamster 
graft-versus-host disease.  On the basis  of these findings,  it was  suggested  that 
alterations  within  this  tissue  represent  the  only  specific  lesions  in  the  GVH 
process,  whereas destruction  of nonlymphoid  tissues,  though  often severe,  can 
be accounted for by nonspecific pathogenetic mechanisms  (10). 
The initial response of F1 hybrid 1)xnphoid tissues to l~yanphocytes from spe- 
cifically  sensitized  parental  strain  donors  was  hypertrophy  of  nodes  and 
spleen. These organs attained maximum size between 10 and 14 days,  and then 
gradually involuted so that by day 35 after inoculation only atrophic remnants 
remained.  In  concert  with  these  fluctuations  in  lymphoid  mass,  the  concen- 
tration  of  lymphocytes  in  the  peripheral  blood  initially rose  and  then  fell  to 
banphopenic  levels by 35 days (11).  One might reasonably expect that the im- 
munologic  competence  of  animals  so  affected  would  be  considerably  blunted, 
and  as  a  prelude  to  a  study  of the  refractory  state  it  seemed  appropriate  to 
determine  their  immunologic  status,  especially  after  the  disease  had  run  its 
acute  course.  In  these  studies  of both  antibody  and  cell-mediated immunity, 
adult  (CB  >(  MHA)F1  hybrids  were  employed  in  which  GVH  disease  was 
2 Tetanus toxoid aluminum phosphate adsorbed ultrafined, diluted  1 : 10 with phosphate- 
buffered saline; Wyeth Laboratories, Philadelphia, Pa. 
3 Tetanus toxoid fluid, diluted 1 : 10 with phosphate-buffered saline; Eli Lilly and Company, 
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incited by MHA-anti-CB  lymphoid cells  injected  intravenously  (200  X  106 
cells) or intracutaneously (30 X  106 cells). 
Immunologic Competence of GVH-A  ffected Hamslers.-- 
Antibody-forming capacity:  The ability of GVH-diseased animals to make 
circulating antibody in response to an antigenic stimulus, tetanus toxoid (TT), 
was assessed. Two groups of experimental animals were available: (a) recipients 
of 200 million donor cells injected intravenously 70-200 days postinoculation, 
and  (b) hosts that had received sublethal intracutaneous injections of attack- 
ing cells 60-150 days previously (see Fig. 1). After a standard TT immunizing 
regimen (see Materials and Methods), none of these animals had demonstrable 
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Days After Immunization 
Antibody production to tetanus toxoid in F1 hybrid hamsters with  GVH  disease 
serum antibody by day 26, and only 27 % ever did develop precipitins for TT 
as revealed by agar gel diffusion. The three hamsters with positive serum were 
all members of group (a); none had received its inciting dose of parental cells 
intracutaneously. For comparison's sake, the responsiveness of normal F1 hybrid 
hamsters  to  the  same  immunizing regimen was  determined and  is  also  pre- 
sented in Fig.  1; while sera from a few normal animals contained TT-preeipi- 
tating antibody on day 26,  by day 35 virtually all were positive. It was con- 
cluded that GVH-affected hamsters have a reduced capacity to form antibody 
in response to a conventional antigenic stimulus. 
Cell-mediated immune response:  The cell-mediated aspect  of immunologic 
responsiveness was  assessed  in  these  animals  by determining  their  capacity 
to reject skin grafts from homologous (PD4 hamster) and heterologous (DA rat) 
donors. The isogenic PD4 strain  differs from both parental  strains  (CB  and 
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time  (MST)  of orthotopically  grafted  PD4  skin  on normal  (CB  X  MHA)Fx 
hybrid recipients was short: 11.9 -4- 0.6 days. Of the test animals challenged with 
PD4 skin,  group  1  (Table  I)  comprised  18  adult  (CB  X  MHA)F1 recipients 
of  200  X  10  ~ MHA-anti-CB  lymphoid  cells  injected  intravenously  17-140 
days previously.  10 animals  utterly  failed  to reject  the homologous skin  and 
displayed  perfect  grafts with  abundant  white  fur  100 days later.  Grafts  that 
ultimately  were  rejected  survived  for  considerably  longer  periods  than  the 
normal  MST.  This  evidence  seemed  sufficient  to  implicate  deficient  primary 
cellular hypersensitivity in animals suffering from GVH disease. 
TABLE I 
Survival  Times of PD4 Skin Grafts on (CB )< MHA )F1 Hybrids  with Graft-Versus-Host  Disease 
Recipients  No.  Survival times*  Group  (CB X MHA)F~ hybrids that: 
1  Received 200 million MHA-anti- 
CB cells i.v. 17-60 days pre- 
viously 
2  Were presensitized to PD4 anti- 
gens, then received 200 million 
MHA-anfi-CB cells i.v. 17-30 
days previously 
3  Received 200 million MHA-anti- 
CB and anti-PD4 cells 
i.v. 17 days previously 
18 
d~ys 
13-14-14-15-16-16-18-23->  100 X  10 
11-17-19-28-31->i00 X 2 
9  (tl)-13-(13)-15-(18)-(18)->50  X 3~ 
* Median  survival  time of PD4 skin on normal  (CB  X  MHA)F1 hybrid recipients  = 
11.9 4-  0.6 days. 
:~ Numbersin parentheses represent animals that died with epidermal necrolysis before re- 
.ectlng their grafts. 
A  second panel  of hybrids  (group 2, Table I) were specifically sensitized  to 
PD4 tissue isoantigens  by exposure  to first-  and  second-set  skin  homografts, 
after which GVH reactivity was initiated by the intravenous inoculation of 200 
X  10  ~  MHA-anti-CB lymphoid cells. When challenged orthotopically with PD4 
skin homografts 14-30 days thereafter,  none mounted an accelerated rejection 
process and only one rejected its graft by 11 days. Six grafts survived beyond 
16 days, and two remained healthy as long as 100 days. Clearly, not even pre- 
existent  cellular  immunity  in  these  animals  could  weather  the  rigors  of  a 
systemic GVH reaction. 
GVH disease was then induced in a third group of F1 hosts by the intravenous 
injection  of 1)n~nphoid  cells  derived  from MHA  donors  specifically sensitized 
to  CB  and  PD4 transplantation  antigens.  This panel  was subsequently  chal- 
lenged with PD4 skin  grafts,  and,  as the results  of Table I  indicate,  the pat- 
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groups.  Once  again  defective  cell-mediated  immunity  was  demonstrated 
even though  the  GVH-inducing lymphoid cells had  been obtained from ani- 
mals specifically immunized to the antigens on the test skin grafts. 
It is worth pointing out that several animals in group 3 died during the course 
of  the  grafting  experiment  (numbers  in  parentheses,  Table  I).  For  reasons 
which  are  obscure,  all  of these  animals  developed toxic epidermal necrolysis 
5-7  days  after  the  application  of  PD4  grafts.  In  no  previous  experimental 
situation had  intravenous recipients of parental  lymphoid cells acquired the 
TEN  syndrome  (2),  and  it  was  therefore surprising  to  discover it  in  these 
animals. Whether its development was in any way related to the specific sensi- 
tivity of donor cells to PD4 graft antigens is conjectural. 
In  additional  studies  bearing  on immunologic competence, hamsters  with 
GVH disease rejected rat skin heterografts quite promptly, within 6 days, an 
interval  quite  similar  to  that  of normal  hamsters.  The  preservation  of  this 
modality of immune capacity in the face of obvious incompetency with respect 
to  other  antigenic  systems  is  not  surprising  in  light  of  the  potency of  this 
heterologous stimulus,  and  thus  underscores  the  fact  that  the  immunologic 
deficiency in  these animals was incomplete. 
In summary, graft-versus-host  disease significantly impaired certain primary 
and  secondary cellular immune  capabilities  in  adult  hamsters;  more impres- 
sively, it prevented the expression of preexistent, donor-based, cellular hyper- 
sensitivity to a  third or unrelated set of tissue isoantigens,  suggesting that a 
defect in the central or efferent limb of the immunologic reflex was involved. 
Studies on Refractoriness  in, GVH-A  ffected Hamsters.--Epidermolysis  stands 
alone as the single most reliable clinical indicator of graft-versus-host  disease 
in hamsters,  namely, normal  adult F1 hybrid recipients of 200  )<  106 MHA- 
anti-CB  lymphoid  cells injected intracutaneously without  exception develop 
this  severe cutaneous disorder within  10  days  (1).  Thus  the  capacity to  ex- 
press epidermolysis upon similar challenge was selected as the means by which 
an  animal  with  chronic GVH disease  could be characterized as refractory or 
not.  An  initial  panel  of  17  F1  hosts  was  available  for  testing,  14  of whom 
had  received  their  GVH-inciting  lymphoid  cells  intravenously  40-150 days 
previously (Table II). None of these latter animals evinced the slightest evi- 
dence  of  epidermolysis  when  challenged  intracutaneously  with  200  million 
MHA-anti-CB  cells,  whereas  the  three remaining hosts in  the panel,  having 
received their original  donor cells  195 days previously, did  exhibit mild  epi- 
dermolysis of insufficient severity to  procure their  demise.  It  would  appear 
that hamsters with chronic GVH disease become refractory to a recrudescence 
of  GVH  reactivity upon  rechallenge  with  lymphoid  cells  of  original  donor 
genotype. 
In searching for an explanation for this phenomenon, it was considered that 
F~  hybrid  hosts  might  be  capable  of mounting  an  immune  response  to  un- 
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tivitv  could preclude  the subsequent  engraftment of donor cells.  To test this 
idea,  a panel of 12  putative refractory F~ hybrids were grafted orthotopically 
with skin from both MHA and CB parental strain donors. No animal  showed 
the slightest inclination to reject either type of skin  (all grafts survived indef- 
initely); therefore, it seemed extremely unlikely that an obscure host inmmnity 
could have prevented epidermolysis by prejudicing the "take" of a subsequent 
inoculum  of  MHA  lymphoid  cells.  Moreover,  the  indefinite  survival  of  CB 
skin grafts on these animals merely reemphasized the earlier observation that 
as the  GVH reaction  unfolds,  even the  attacking  donor lymphoid cells  seem 
to lose their immunologic commitments, in  this case, against CB  transplanta- 
tion  antigens. 
Another hypothesis to account for refractoriness takes cognizance of the im- 
munologic  incompetence  of  GVH-affticted hamsters,  maintaining  that  a  de- 
TABLE  II 
Capacity  of Inlracutaneously  Injected  MHA  anti-CB  Lymphoid ('ells to Incite  Epidermolysis 
in (CB  X  MHA )F1 Hybrids Previously Injected Intravenoz¢sly with MHA  anti-CB 
Lymphoid Cells 
Interval between first injection  (i.v.)  No. of animals tested  No. with eDidermo]ysis 
and second  injection  (i,c.) 
days 
40 
9O 
110 
150 
195 
2  0/2 
4  0/4 
6  0/6 
2  o/2 
3  3/3 
ficiency  in  the  central  and/or  efferent  limb  of  the  immunologic  reflex  arc 
precludes  the mediation  and  expression of further  GVH reactivitv.  Evidence 
bearing  on  this  idea  was  sought  by challenging  each  of 20  MHA-refractorv 
F1  hybrids  intracutaneously  with  200  X  10  ~ lymphoid  cells  from CB  strain 
donors sensitized to MHA antigens  (Table III). 18 of these animals developed 
severe epidermolysis and died, indicating that they had suffmient immunologic 
competence and efferent "mediators" to exhibit epidermolysis if the challenge 
were  genetically  appropriate,  i.e.,  immunologically  competent  cells  from the 
other parental strain. 
On  suspicion  that  the  appearance  of  refractoriness  might  depend  upon 
the  time elapsed after initiation  of GVH disease,  a  series of experiments was 
conducted  in  which  small  groups  of  F1  recipients  of  intravenously  injected 
MHA lymphoid cells were rechallenged intracutaneously with  MHA  anti-CB 
cells  at  regular  intervals  thereafter:  4,  7,  14,  21,  28,  35,  49,  and  100  days. 
Inlracutaneous  inoculation  sites  containing  10  X  1()  ~ cells  were  scored  24, 
48,  and  72  hr  later  as  immune  lymphocyte  transfer  reactions  (ILTR),  and 
the  animals  were  scrutinized  for  the  appearance  of  epidermolysis.  Their J.  WAYNE  STREILEIN  573 
ability  to  display  ILTR's became  attenuated  within  7  days  after  initiation 
of  GVH  disease  (Table  IV),  and  by  35  days  intracutaneous  injections  of 
donor cells incited no response whatever.  Similarly,  as early  as  7  days,  some 
animals  exhibited  relative  refractoriness,  which  persisted  through  the  first 
28 days after which the typical cutaneous syndrome, even in mild form, could 
TABLE III 
Capacity of Intracutaneously Injected CB-anti-MHA  Lymphoid Cells to Incite Epidermolysis 
in (CB X  MHA)Ft Hybrids Previously Injected Intravenously with MHA-antI-CB 
Lymphoid Calls 
Interval between first injection  (i.v.)  and second injection  (i.c.)  No. of animals tested  No. with  epidermolysis 
days 
45  6  6/6 
55  8  8/8 
70  6  4/6 
TABLE IV 
Relationship of Immune Lymphocyte Transfer Reactions to the Development of the Refractory State 
Days after inoculation*  No. of animals tested  No. with r~ositive  No. with epidermolysis  ILTR's 
4  4  4  4/4 
7  6  2  4/6 
14  6  2  2/6 
21  4  2  2/4 
2(sl)* 
28  4  4  2/4 
2(sl):~ 
35  6  0  0/6 
49  5  0  0/5 
loo  5  0  0/5 
* (CB X  MHA)FI hybrids  received 200 million MHA-anti-CB lymphoid  cells intrave- 
nously on day 0, and were then challenged intracutaneously  with 200 million MHA-anti-CB 
lymphoid cells at the above intervals. 
Developed very mild epidermolysis. 
no  longer  be  elicited.  This  absolute  refractoriness  persisted  throughout  the 
100 day limit  on the  experiment.  It was particularly interesting  to note that 
in every case, a  positive ILTR served as a  harbinger of epidermolysis,  and in 
only two instances did a  negative ILTR precede the appearance of epidermol- 
ysis.  This highly impressive  association  between  intense  local GVH reactions 
and  epidermolysis  strongly  suggested  that  the  two  events  might  be  causally 
related. 
An essential  prerequisite  to the  development  of ILTR's in hamster  skin is 
adequate  numbers  of  genotypically  appropriate  circulating  lymphocytes.  In 574  RE~FRACTORY  STATE  AND  IMMUNOLOGIC  COMPETENCE  OF  GVIL 
a  previous  report it  was shown  that  FI recipients  of 200 million MHA  cells 
injected intravenously developed severe lyrnphopenia within  28  35  days,  and 
it seemed reasonable to suspect that the appearance of refractoriness in hamsters 
with  chronic GVH disease may result from a  deficiency of target tissue,  i.e., 
host lymphoid cells.  In an attempt to validate this hypothesis, several experi- 
ments were carried out in an effort to abolish the refractory state by providing 
additional target F~ lymphoid cells. 
Reconstitution Experiments  in Refractory Hamsters.--In the first experiment 
in this series, a  panel of six intravenous recipients of 200 million MHA-anti- 
CB  lymphoid cells, 35  or more days postinoculation  (hereafter referred to as 
refractory), were injected intravenously with one donor equivalent of (CB  X 
MHA)FI bone marrow cells on the presumption that the diminished supply of 
circulating lymphoid cells in these animals could thus be  replete& When  this 
TABLE  V 
Summary of Experiments Designed to Abolish the Refractory State 
Experiment  No. of animals  No. with 
tested  epidermolysis 
One donor equivalent (CB X MHA)F1 bone marrow cells; i.c.  6 
challenge with MHA-anti-CB cells 7 days later 
900 R followed by one donor equivalent (CB X MHA)F1  10 
bone marrow cells; i.c. challenge  with MHA-anti-CB cells 
3 wk later 
i.c. challenge with mixtures of MHA-anti-CB and (CB ;K  6 
MHA)F1 lymphoid cells 
0 
10 
Test animals were (CB  X  MHA)F1 hybrids that received intravenous injections of 200 
million MHA-anti-CB lymphoid ceils 50 days before. 
panel was challenged intracutaneously  2-7  days later  (Table V)  with  200  X 
106 MHA-anti-CB ceils,  no sign of epidermal disease was observed. Although 
direct evidence was not obtained,  it was suspected that the injected hemato- 
poietic  cells  may  not  have  established  effective  residence,  by virtue  of  the 
persistent GVH potential of the original MHA lymphoid cells or their progeny 
residing within these hosts. 
In an attempt to insure the engraftment of F1 bone marrow ceils,  10 refrac- 
tory F1 hosts were exposed to 900 R  whole body X-irradiation,  and each was 
reconstituted 24 hr later with one donor equivalent of (CB ×  MHA)F1 hemato- 
poietic  cells.  Every  animal  survived  the  irradiation  and  was  challenged  in- 
tracutaneously 21  days later with 200 million MHA-anti-CB  lymphoid cells. 
Severe epidermolysis and death ensued within 3 wk in all hosts, indicating that 
systemic  reconstitution  with  F1  hematopoietic  stem  cells  had  taken  place, 
and that refractoriness had been abolished  (Table V). 
Lastly, an attempt was made to effect a  similar reversion of refractoriness 
by supplying the putative target lymphoid cells locally in the inciting cutane- j.  WAYNE STREILEIN  575 
ous inoculum. F1 hybrids made refractory by the previous intravenous injec- 
tion of MHA-anti-CB  cells were injected intracutaneously with a mixture of 
monodisperse lymphoid cells derived from MHA-anti-CB and (CB X  MHA)F1 
donors.  As  expected  (TabIe V),  intense inflammatory reactions  appeared  at 
the  cutaneous  inoculation  sites  of five animals,  and  shortly  thereafter full- 
blown epidermolysis developed, demonstrating that  the refractory state  had 
in this instance been circumvented by providing target lymphoid cells locally 
as well as systemically. 
DISCUSSION 
There appear to be three ways in which a  GVH process can result in  the 
development of refractoriness (see Table VI):  by inducing  alterations in  (a) 
TABLE VI 
Refractoriness  in GVII Disease:  Possible Pathogenetic Mechanisms 
Alterations in host reactivity: 
Development of host-anti-donor immunity 
Impairment of immunologic  competence 
Depletion of nonspecific  mediators 
Alteration in donor cell reactivity: 
Elimination through self-destruction (allergic  suicide) 
Conversion to tolerance of host antigens 
Limitation to continued proliferation 
Alteration in host antigenicity: 
Masking by donor isoantibody 
Deletion of tissue isoantigens from individual cells 
Depletion of specific  target tissue. 
host reactivity, (b) original donor cell reactivity, and/or host antigenicity. It 
is  reasonably  well  established  that,  since  the  genes  operating  at  histocom- 
patibility loci function as codominants, F1 hybrids are genetically incapable of 
mouting  a  specific immunologic response  to  grafts  of tissues  and  cells from 
either parental strain. 
However, there are  unequivocal reports of somewhat unique  genetic rela- 
tionships wherein this general rule seems not to apply, e.g. hematopoietic cells 
from  C57BL  murine  donors  survive only very poorly in  lethally irradiated 
(A X  C57BL)FI hybrids (12), and circumstantial evidence has been advanced 
which implies that an immunologic mechanism is responsible (13). In the case 
of Syrian hamsters, the ease with which (CB  X  MHA)F1 hybrid hosts can be 
spared  irradiation  sickness  by  the  provision  of  MHA  helnatopoietic  cells 
indicates that this particular genetic relationship behaves according to tradi- 
tional  precepts.  Moreover,  the  failure of MHA-refractory animals  to  reject 
MHA skin homografts attests to the validity of this interpretation. 
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immunologic  responsiveness  are  deficient  in  refractory  hamsters.  However, 
these deficiencies are relative rather than  absolute,  and the  observation that 
MHA-refractory  animals  can  develop  epidermolysis  upon  intracutaneous 
challenge with  CB-anti-MHA  lymphoid cells  indicates  that  neither putative 
depletion of nonspecific mediators,  nor relative immunologic incompetency is 
responsible in an)" major way for the appearance of the refractory state. 
With  regard  to  postulated  alterations  in  the  reactivity of  original  donor 
cells,  it  was  found  that  suspensions  of F1 bone marrow  cells failed to  erase 
refractoriness except when preceded by whole body X-irradiation. Clearly not 
all of the donor cells had con~rnitted imnmnologic suicide, but instead at least 
some  remained  viable  within  their  hosts  in  a  manner  that  had  to  be  sup- 
pressed in order for a graft of F1 marrow cells to take. Yet, evidence of mod- 
erate  alterations  in  the  reactivity  of  donor  cells  was  obtained;  F1  hybrids 
harboring these cells failed to reject grafts of PD4 hamster skin with normal 
vigor,  even  if  the  original  donors  had  been  specifically  sensitized  to  PD4 
isoantigens. While  this evidence implied that the lymphoid cells in the initial 
donor inoculum  had  indeed  undergone  a  functional  alteration,  the  role  this 
transformation played in the development of refractoriness remained obscure. 
It is  the  major thesis  of this  report that  alterations in  antigenicity of the 
host are primarily responsible for the emergence of refractoriness in FI hybrid 
hamsters with  GVH disease.  Syrian hamsters may be unique among animals 
studied to date in the almost absolute requirement for lymphoid cells  as anti- 
genic targets  in  a  variety of cellular immune  reactions  of homologous type. 
In  immune  lymphocyte  transfer  reactions  in  normal  hamsters,  circulating 
lymphoid cells  and not parenchymatous cutaneous cells provide the antigenic 
stimulus  (14),  while in  skin  tests  performed in  lethally irradiated  hamsters, 
target  lymphoid  cells  must  be  admixed  with  immunocompetent  attacking 
cells in order to evoke a positive local inflammatory reaction (9). 
Similarly the expression of systemic GVH disease in hamsters, as evidenced 
by  the  epidermolytic syndrome,  is  almost  totally dependent upon  the  pres- 
ence of circulating leukocytes of appropriate antigenic constitution within the 
host, whose own genotype, incidentally, may even be irrelevant (2). It is not 
too surprising,  therefore, that  the  virtual  ablation  of host  lymphatic tissues 
procured by the inoculum of attacking cells should leave insufficient numbers 
of lymphoid cells to serve as immunologic targets for a subsequent inoculation 
of attacking  cells  isologous  to  the  original  donor strain.  However, there did 
appear to be sufficient MHA cells persisting within these hosts to allow a sub- 
sequent inoculation of lymphoid cells  from  the other parental  strain,  CB,  to 
perceive  them  as  targets,  overcome refractoriness,  and  evoke epidermolysis. 
In this report, reconstitution experiments in which viable F1 leukocytes were 
provided either systemically or locally as adjuncts to the rechallenge inoculum 
of MHA  cells  successfully nullified  the  refractory state,  thereby reenforcing J.  WAYNE  STREILEIN  577 
the notion that host lymphoid cells play a pivotal role in the pathogenesis of 
the acute GVH syndrome and one of its sequela,  the refractory state. 
It  would  be  inappropriate  to  extrapolate  directly from  these  findings  to 
account for comparable experimental results  in  other  species.  Unlike  in  the 
hamster,  refractoriness  in  rats  and  mice  extends  to  both  parental  strains 
(3,  15),  irrespective of which had served as original donor. In addition, it has 
been suggested  that  in  these latter  species,  donor cell-secreted isoantibodies 
(in a manner reminiscent of enhancement) gradually blunt the continued attack 
of donor effector cells,  thus allowing their hosts to recover and exhibit refrac- 
toriness to rechallenge. Hamsters, at least the strains employed in these experi- 
ments, do not appear to make isoantibodies to transplantation antigens  (16), 
yet many of them do in fact recover from acute GVH disease and become re- 
fractory. The homology between the experience with hamsters  and with iso- 
antibody-producing species may be that if lymphoid cells are the major target 
tissue  in  GVH  disease,  irrespective of  species,  attenuation  of  the  disease  is 
obtained either by obliteration of that tissue or by masking its presence with 
specific immunoglobulins.  Donor cells themselves are  able  to  effect both  re- 
sults, and by the same means render their hosts refractory to rechallenge. 
SUMMARY 
The so-cailed refractory state, one sequela of acute graft-versus-host  disease, 
has been studied in adult (CB  X  MHA)F1 hybrid Syrian hamsters inoculated 
with  sublethal  numbers  of  MHA-anti-CB  lymphoid  cells.  Intracutaneous 
challenge of these animals with 200 million MHA-anti-CB lymphoid cells after 
the acute syndrome subsided failed to evoke epidermal necrolysis, whereas a 
similar challenge administered to normal  F1 recipients invariably resulted in 
lethal epidermolysis. Moreover, the gradual  attrition of lymphatic tissues  in 
these hosts and their fading capacity to display adequately immune lympho- 
cyte transfer reactions in the skin coincided with increasing evidence of host 
refractoriness,  suggesting  a  causal  interrelationship.  It  was  possible  to  cir- 
cumvent  refractoriness  by  challenging  these  animals  intracutaneously  with 
MHA-anti-CB  cells if:  (a)  the hosts had been lethally irradiated  and recon- 
stituted with F~ hematopoietic cells, or (b) the intracutaneous inocula contained 
admixed F1 lymphoid cells.  This evidence provides additional support for the 
hypothesis  that  in  GVH  disease  donor  lymphocytes  attack  primarily  host 
lymphoid cells bearing offending homologous antigens. The GVH process can 
continue so long as these lymphocyte-bound antigens persist within the host, 
and  will  abate  only as  the  aggregate host  lymphatic mass  is  effectively de- 
stroyed (hamsters)  or its antigenic determinants are masked by isoantibodies 
(rats, mice, man?). At this point, insufficient target tissues remain for rechal- 
lenge to incite significant recrudescence of the disease. 
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